Delivery Order SPE2DR25D1017-SPE2DR26F8YVS
Award Date 10/31/25
Potential Completion Date 11/3/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,044.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 300 mg (100 mg x 3 syringe/ml) on June 2, 2025, with completion scheduled for June 3, 2025. This non-set-aside award was competitively procured and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,562.51 on September 18, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL) under a Defense Logistics Agency Medical Supply Chain contract. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task against...
- The Defense Logistics Agency awarded a delivery order valued at $3,116.22 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emgality 120 mg/ml in pen format. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. Emgality is a monoclonal antibody treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product Emgality 120 mg/mL pen on May 20, 2025, with a ceiling value of $1,037.40. This firm fixed-price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Emgality 120 mg/mL pen injectors, with a ceiling value of $1,037.40. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody indicated for migraine prevention, representing a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,729.00 for Emgality 120mg/ml on August 27, 2025. This non-competitive, firm fixed-price delivery order is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by August 28, 2025. Emgality is a calcitonin gene-related peptide (CGRP) receptor antagonist used for migraine prevention, representing the type of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Emgality 120 mg/ml pen injectors, valued at $3,458.00. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 7, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml in pre-filled pen format. This non-competitive, firm fixed-price delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Emgality is a calcitonin gene-related peptide (CGRP) antagonist used for migraine prevention,...
- The Defense Logistics Agency awarded a $5,864.45 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on September 4, 2025, with completion targeted for September 5, 2025. This non-competitive delivery order represents a firm fixed price transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody...
- The Defense Logistics Agency awarded a $2,172.80 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody used for migraine prevention, indicating this order supports the federal government's...